Novel potential NOX2 inhibitors, Dudleya brittonii water extract and polygalatenoside A inhibit intracellular ROS generation and growth of melanoma

Reactive oxygen species (ROS) are key regulators of the proliferation, metastasis, and drug resistance of mela-noma, which accounts for 60% of skin cancer deaths. In a previous study, we developed Dudleya brittonii water extract (DBWE) with antioxidant activity, but the mechanism of action and bioactive substances of DBWE have not been fully identified. This study showed altered NADPH oxidase 2 (NOX2) expression and selective inhibition of cytosolic ROS but not mitochondrial ROS in B16-F10 melanoma cells, suggesting the NOX2 inhibitory po-tential of DBWE. In addition, DBWE inhibited mitochondrial activity, lipid metabolism, and cell cycle in B16-F10 cells. The anti-melanoma effect of DBWE was abrogated by the addition of ROS, and there was no significant change in the melanogenesis pathway. Polygalatenoside A was identified as a candidate bioactive substance in the DBWE aqueous fraction through mass spectrometry, and the DBWE-like anti-melanoma effect was confirmed. These data suggest that DBWE and polygalatenoside A have the potential to prevent and treat melanoma.

Automated summary

Reactive oxygen species (ROS) play a crucial role in regulating the proliferation, metastasis, and drug resistance of melanoma, and the inhibition of NOX2 and cytosolic ROS by Dudleya brittonii water extract (DBWE) and its bioactive substance polygalatenoside A may contribute to the prevention and treatment of melanoma. DBWE also inhibits mitochondrial activity, lipid metabolism, and cell cycle in B16-F10 melanoma cells.